Page last updated: 2024-11-05

thalidomide and Hyperesthesia

thalidomide has been researched along with Hyperesthesia in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Hyperesthesia: Increased sensitivity to cutaneous stimulation due to a diminished threshold or an increased response to stimuli.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, JT1
Xin, WJ1
Zang, Y1
Wu, CY1
Liu, XG1
Youle, M1
Hawkins, D1
Gazzard, B1

Other Studies

2 other studies available for thalidomide and Hyperesthesia

ArticleYear
The role of tumor necrosis factor-alpha in the neuropathic pain induced by Lumbar 5 ventral root transection in rat.
    Pain, 2006, Volume: 123, Issue:3

    Topics: Animals; Anterior Horn Cells; Behavior, Animal; Foot; Ganglia, Spinal; Hindlimb; Hot Temperature; Hy

2006
Thalidomide in hyperalgic pharyngeal ulceration of AIDS.
    Lancet (London, England), 1990, Jun-30, Volume: 335, Issue:8705

    Topics: Acquired Immunodeficiency Syndrome; Humans; Hyperalgesia; Hyperesthesia; Pharyngeal Diseases; Stomat

1990